-
COVID-19 vaccine from Anhui earns conditional approval
2022-03-04
China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.
-
Over 3.13b COVID-19 vaccine doses administered on Chinese mainland
2022-03-03
The number of COVID-19 vaccine doses administered on the Chinese mainland grew by around 5.75 million from the previous day to reach over 3.13 billion on Tuesday, data from the National Health Commission showed on March 2.
-
Number of new local COVID-19 cases on Chinese mainland continues to drop Wednesday
2022-03-03
The Chinese mainland on Wednesday reported 54 locally transmitted COVID-19 cases, 17 fewer than the day before, the National Health Commission said on March 3.
-
Over 3.12b COVID-19 vaccine doses administered on Chinese mainland
2022-03-02
The number of COVID-19 vaccine doses administered on the Chinese mainland grew by around 5.73 million to reach over 3.12 billion on Monday, data from the National Health Commission showed on March 1.
-
Chinese mainland reports 71 new local COVID-19 cases Tuesday
2022-03-02
The Chinese mainland on Tuesday reported 71 locally transmitted COVID-19 cases, the National Health Commission said on March 2.
-
Inactivated poliomyelitis vaccine developed by Sinopharm gains WHO’s pre-qualification
2022-03-01
The World Health Organization (WHO) recently announced that the Sabin strain (Vero cell) inactivated poliomyelitis vaccine (sIPV) developed by Sinopharm Group's Beijing Institute of Biological Products has been pre-qualified and is available for procurement by the United Nations system.
